Terms: = Thyroid cancer AND PDGFB, SIS, 5155, ENSG00000100311, FLJ12858, PDGF2, P01127, c-sis, SSV AND Treatment
8 results:
1. A prospective study comparing the gasless endoscopic thyroidectomy trans-axillary approach to conventional open thyroidectomy: health and quality of life outcomes.
Xu T; Qin X; Zhang Y; Li P; Ran Y; Fan Y; Zheng X; Wei T
Surg Endosc; 2024 Apr; 38(4):1995-2009. PubMed ID: 38396084
[TBL] [Abstract] [Full Text] [Related]
2. [Preliminary experience of gasless transoral vestibular robotic thyroidectomy].
Liang FY; Lin PL; Lin XJ; Han P; Chen RH; Wang JY; Zou X; Huang XM
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2023 Jun; 58(6):596-601. PubMed ID: 37339900
[No Abstract] [Full Text] [Related]
3. Pictorial Representation of Illness and Self Measure-Revised 2 (PRISM-R2): an effective tool to assess perceived burden of thyroid cancer in mainland China.
Wang Y; Fan S; Wang H; Li L; Jia Y; Chai L
Support Care Cancer; 2018 Sep; 26(9):3267-3275. PubMed ID: 29644472
[TBL] [Abstract] [Full Text] [Related]
4. RET mutation and increased angiogenesis in medullary thyroid carcinomas.
Verrienti A; Tallini G; Colato C; Boichard A; Checquolo S; Pecce V; Sponziello M; Rosignolo F; de Biase D; Rhoden K; Casadei GP; Russo D; Visani M; Acquaviva G; Ferdeghini M; Filetti S; Durante C
Endocr Relat Cancer; 2016 Aug; 23(8):665-76. PubMed ID: 27402614
[TBL] [Abstract] [Full Text] [Related]
5. Aberrantly expressed mRNAs and long non-coding RNAs in patients with invasive ductal breast carcinoma: a pilot study.
Chen X; Yang J; Qian L; Cao T
Mol Med Rep; 2015 Mar; 11(3):2185-90. PubMed ID: 25411894
[TBL] [Abstract] [Full Text] [Related]
6. BRAF(V600E) mutation and expression of proangiogenic molecular markers in papillary thyroid carcinomas.
Durante C; Tallini G; Puxeddu E; Sponziello M; Moretti S; Ligorio C; Cavaliere A; Rhoden KJ; Verrienti A; Maranghi M; Giacomelli L; Russo D; Filetti S
Eur J Endocrinol; 2011 Sep; 165(3):455-63. PubMed ID: 21653734
[TBL] [Abstract] [Full Text] [Related]
7. Paneling human thyroid cancer cell lines for candidate proteins for targeted anti-angiogenic therapy.
Hoffmann S; Wunderlich A; Celik I; Maschuw K; Hassan I; Hofbauer LC; Zielke A
J Cell Biochem; 2006 Jul; 98(4):954-65. PubMed ID: 16475167
[TBL] [Abstract] [Full Text] [Related]
8. Excessive activation of tyrosine kinases leads to inhibition of proliferation in a thyroid carcinoma cell line.
Broecker M; Hammer J; Derwahl M
Life Sci; 1998; 63(26):2373-86. PubMed ID: 9877227
[TBL] [Abstract] [Full Text] [Related]
